Beta adrenergic antagonists and antianginal drugs are used with the aim to ultimately
decrease mortality and enable patients to lead an improved quality of life by avoidance of …

Beta adrenergic antagonists and antianginal drugs are used with the aim to ultimately
decrease mortality and enable patients to lead an improved quality of life by avoidance of …

At present, there is no effective drug against the present coronavirus disease 2019 (COVID-
19) pandemic. It is known that severe acute respiratory syndrome coronavirus 2 (SARS-CoV …

The COVID-19 pandemic led to an enormous burden on healthcare systems worldwide.
Causal therapy is still in its infancy. Contrary to initial views that the use of angiotensin …

More than 15 million people have been affected by coronavirus disease 2019 (COVID‐19)
and it has caused 640 016 deaths as of July 26, 2020. Currently, no effective treatment …

Background Alpha‐1 receptor antagonists may interfere with IL‐6 signaling and could
therefore be a potential treatment for COVID‐19. However, the effectiveness of these drugs …

Aims: To update our previously reported systematic review and meta‐analysis of
observational studies on cardiovascular drug exposure and COVID‐19 clinical outcomes by …

Beta-adrenergic antagonists and antianginal drugs aim to have beneficial effects in the
treatment of cardiovascular diseases. Each class has a variety of actual or potential side …

There has been a lot of speculation that patients with coronavirus disease 2019 (COVID-19)
who are receiving angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor …

No medications specific treatments are known to be effective for COVID-19 until now.
Several drug therapies are being used to optimize supportive care to relieve symptoms …